OSR Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OSR Health, Inc. on August 25, 2026. The company is incorporated in Delaware and its principal executive offices are located in Bellevue, WA. The report addresses a critical regulatory event concerning the listing status of the company's securities on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance and listing compliance matters rather than financial performance data.
Material Changes and Events
- Delisting Determination: Nasdaq notified the company of a determination to delist its common stock (OSRH) and redeemable warrants (OSRHW) due to non-compliance with the minimum bid price requirement (Listing Rule 5550(a)(2)).
- Trading Suspension: Trading in the company's securities is scheduled to be suspended at the opening of business on August 26, 2026. This suspension will proceed despite the company's appeal.
- Formal Delisting Stayed: The company submitted a request for a hearing before a Nasdaq Hearings Panel on August 25, 2026. This timely request is expected to stay the filing of Form 25-NSE, which would formally delist the securities, pending the Panel's decision.
- Compliance History: The company had previously been granted a second 180-day compliance period.
Outlook, Risks, and Management Commentary
Management intends to present a plan at the hearing to demonstrate the ability to regain and sustain compliance with Nasdaq listing requirements. However, the filing explicitly states there can be no assurance that the Panel will grant the request for continued listing or that the company will regain compliance. The report includes standard forward-looking statement disclaimers regarding the uncertainty of the hearing outcome and the potential for actual results to differ materially from expectations.
Investor Verification Checklist
- Verify the status of the Nasdaq Hearings Panel decision regarding the appeal.
- Confirm whether trading in OSRH and OSRHW has been suspended as scheduled on August 26, 2026.
- Monitor for the potential filing of Form 25-NSE if the appeal is unsuccessful.
- Review the specific plan of compliance the company intends to present to the Panel.
- Check for any subsequent announcements regarding the minimum bid price of the stock.